These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 8035602

  • 1. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH.
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [Abstract] [Full Text] [Related]

  • 2. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A, Bussaglia E, Úbeda J, Facchini L, Aventin A, Sierra J, Nomdedéu JF.
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA.
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [Abstract] [Full Text] [Related]

  • 4. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group.
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G.
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [Abstract] [Full Text] [Related]

  • 6. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 7. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG, Portieres FL, Martins SL, Rego EM, Zago MA, Falcão RP.
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [Abstract] [Full Text] [Related]

  • 8. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD.
    Blood; 1994 Jul 01; 84(1):244-55. PubMed ID: 7517211
    [Abstract] [Full Text] [Related]

  • 9. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Jul 01; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 10. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, Falkenrodt A, Lecalvez G, Maynadié M, Béné MC.
    Leukemia; 2003 Mar 01; 17(3):515-27. PubMed ID: 12646939
    [Abstract] [Full Text] [Related]

  • 11. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM, Qian SX, Wu YJ, Qiao C, Hong M, Fan L, Yang H, Zhang JF, Zhang SJ, Wu HX, Qiu HX, Lu H, Xu W, Sheng RL, Li JY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb 01; 17(1):176-9. PubMed ID: 19236773
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U, Mohr B, Schaich M, Schäkel U, Kroschinsky F, Illmer T, Ehninger G, Thiede C.
    Cytometry B Clin Cytom; 2009 Sep 01; 76(5):321-7. PubMed ID: 19291801
    [Abstract] [Full Text] [Related]

  • 15. Expression of cell-surface antigens in acute promyelocytic leukaemia.
    Paietta E.
    Best Pract Res Clin Haematol; 2003 Sep 01; 16(3):369-85. PubMed ID: 12935957
    [Abstract] [Full Text] [Related]

  • 16. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE, Cruse JM, Webb RN, Sanders CM, Beason K.
    Exp Mol Pathol; 2007 Oct 01; 83(2):269-73. PubMed ID: 17603036
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia].
    Liu Y, Chen YT, Li JX, Zhang SH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug 01; 20(4):806-11. PubMed ID: 22931633
    [Abstract] [Full Text] [Related]

  • 19. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
    Gorczyca W.
    Pol J Pathol; 2012 Mar 01; 63(1):8-17. PubMed ID: 22535601
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.